Vidarabine (Vira-A®): Pharmacology and clinical experience
- 31 December 1980
- journal article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 8 (1) , 143-171
- https://doi.org/10.1016/0163-7258(80)90063-7
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Antiherpesvirus Activity in Human Sera and Urines after Administration of Adenine ArabinosideJournal of Clinical Investigation, 1978
- Genital Herpetic Infection in Men and Women: Clinical Course and Effect of Topical Application of Adenine ArabinosideThe Journal of Infectious Diseases, 1976
- In Vitro Susceptibility of Varicella Zoster Virus to Adenine Arabinoside and Hypoxanthine ArabinosideAntimicrobial Agents and Chemotherapy, 1976
- Synergistic Antiviral Effects of Adenine Arabinoside and Humoral Antibodies in Experimental Encephalitis Due to Herpesvirus hominisThe Journal of Infectious Diseases, 1976
- STUDIES ON THE BIOCHEMICAL BASIS FOR THE ANTIVIRAL ACTIVITIES OF SOME NUCLEOSIDE ANALOGS*Annals of the New York Academy of Sciences, 1975
- Determination of Plaque Inhibitory Activity of Adenine Arabinoside (9-β- d -Arabinofuranosyladenine) for Herpesviruses Using an Adenosine Deaminase InhibitorAntimicrobial Agents and Chemotherapy, 1974
- Viral RNA-dependent DNA Polymerase: RNA-dependent DNA Polymerase in Virions of RNA Tumour VirusesNature, 1970
- Metabolic requirements for infection by rous sarcoma virusVirology, 1966
- Metabolic requirements for infection by Rous sarcoma virusVirology, 1966
- The role of deoxyribonucleic acid in the synthesis of Rous sarcoma virusVirology, 1964